Afamelanotide significantly increased the median duration of pain-free direct sunlight exposure from 10 minutes (placebo) to 70 minutes (treatment) over 6 months
Insomnia is not listed among common adverse reactions in FDA prescribing information for Mounjaro or Zepbound, and clinical trials did not identify it as a statistically significant side effect
To search for the best healthcare providers worldwide, please use the Mya Care search engine
5.2 Parkinsons disease Parkinsons disease is the second most common chronic and late-onset neurodegenerative disease after Alzheimers disease, with clinical features including slowness of facial expression, increased muscle tension throughout the body, bradykinesia, progressive resting tremor, and dementia (Heusinkveld et al., 2018)
The progression of the field from single-omics discovery towards robust multi-omics verification is exemplified by the growing body of work summarized (Table 1)
This activation promotes synaptogenesis, neurogenesis, and neuronal survival by mimicking or potentiating brain-derived neurotrophic factor (BDNF)-like activity, enhancing synaptic connectivity and cognitive plasticity
